Digital Therapeutics: A New Frontier in Treatment
DOI:
https://doi.org/10.47941/ijhs.3024Keywords:
Digital Therapeutics, Chronic Disease Management, Behavioral Therapy, Mobile Health.Abstract
Purpose: This study aims to explore the evolution, applications, and potential of Digital Therapeutics (DTx) in transforming modern healthcare, particularly in managing chronic diseases, mental health, and behavioral conditions. It seeks to analyze how DTx bridges the gap between traditional medical practices and the growing digital innovation landscape in healthcare.
Methodology: The research adopts a structured analytical approach involving the examination of current DTx applications, synthesis of clinical trial results, and development of a conceptual framework for effective DTx implementation. It evaluates mechanisms of action, regulatory standards, clinical validations, and technological integrations such as artificial intelligence (AI), machine learning (ML), and big data analytics.
Findings: The study highlights significant improvements in patient outcomes, particularly in the management of diabetes, cognitive behavioral therapy (CBT), and substance abuse through DTx solutions. It identifies key benefits including better patient adherence, enhanced scalability, and improved cost-effectiveness when compared to traditional treatments. However, it also recognizes persistent challenges such as regulatory ambiguity, data privacy concerns, limited integration with existing healthcare infrastructure, and variable patient engagement.
Unique Contribution to Theory, Practice, and Policy (Recommendations): This paper contributes to theoretical understanding by framing a conceptual model for DTx implementation and adoption. Practically, it emphasizes the value of AI-driven personalization in therapy and the importance of real-time data tracking in patient care. Policy-wise, it calls for clearer regulatory pathways, robust data governance frameworks, and cross-sector collaboration among clinicians, regulators, technologists, and patients. The research underscores the necessity of a unified ecosystem to fully realize the potential of digital therapeutics in mainstream healthcare.
Downloads
References
Lee, U., Jung, G., Ma, E. Y., San Kim, J., Kim, H., Alikhanov, J., ... & Kim, H. (2023). Toward data-driven digital therapeutics analytics: Literature review and research directions. IEEE/CAA Journal of Automatica Sinica, 10(1), 42-66.
Jat, A. S., & Grønli, T. M. (2023, August). Harnessing the digital revolution: a comprehensive review of mHealth applications for remote monitoring in transforming healthcare delivery. In International Conference on Mobile Web and Intelligent Information Systems (pp. 55-67). Cham: Springer Nature Switzerland.
Jayathissa, P., & Hewapathirana, R. (2023). Enhancing interoperability among health information systems in low-and middle-income countries: a review of challenges and strategies. arXiv preprint arXiv:2309.12326.
Sun, H., Jalam, S. M., Kodali, H., Nerella, S., Zapata, R. D., Gravina, N., ... & Rashidi, P. (2024, December). Enhancing EHR Systems with data from wearables: An end-to-end Solution for monitoring post-surgical Symptoms in older adults. In Proceedings of the 30th Annual International Conference on Mobile Computing and Networking (pp. 2282-2289).
Hu, P., Hu, L., Wang, F., & Mei, J. (2024). Computing and artificial intelligence in digital therapeutics. Frontiers in medicine, 10, 1330686.
Shafai, G., & Aungst, T. D. (2023). Prescription digital therapeutics: A new frontier for pharmacists and the future of treatment. Journal of the American Pharmacists Association, 63(4), 1030-1034.
Hong, J. S., Wasden, C., & Han, D. H. (2021). Introduction of digital therapeutics. Computer methods and programs in biomedicine, 209, 106319.
Shah, A. M., & Shah, S. V. (2023). Digital therapeutics-a new era in health care. National Journal of Physiology, Pharmacy and Pharmacology, 13(11), 2190-2196.
Barracca, A., Ledda, S., Mancosu, G., Pintore, G., Quintaliani, G., Ronco, C., & Kashani, K. B. (2023). Digital health: a new frontier. Journal of Translational Critical Care Medicine, 5(2), e00018.
Sverdlov, O., Van Dam, J., Hannesdottir, K., & Thornton‐Wells, T. (2018). Digital therapeutics: an integral component of digital innovation in drug development. Clinical Pharmacology & Therapeutics, 104(1), 72-80.
Van Kessel, R., Roman-Urrestarazu, A., Anderson, M., Kyriopoulos, I., Field, S., Monti, G., ... & Mossialos, E. (2023). Mapping factors that affect the uptake of digital therapeutics within health systems: scoping review. Journal of Medical Internet Research, 25, e48000.
Oda, T., & Oda, C. (2023). An analysis of the key drivers of the Japanese digital therapeutics patents: A cross‐sectional study. Health Science Reports, 6(6), e1268.
Lee, A., & Ljubownikow, G. (2024). The road to commercialisation: expanding digital therapeutics across international markets. International Journal of Technology Transfer and Commercialisation, 21(5), 1-25.
Fürstenau, D., Gersch, M., & Schreiter, S. (2023). Digital therapeutics (DTx). Business & Information Systems Engineering, 65(3), 349-360.
Lutz, J., Offidani, E., Taraboanta, L., Lakhan, S. E., & Campellone, T. R. (2022). Appropriate controls for digital therapeutic clinical trials: a narrative review of control conditions in clinical trials of digital therapeutics (DTx) deploying psychosocial, cognitive, or behavioral content. Frontiers in Digital Health, 4, 823977.
Armeni, P., Polat, I., De Rossi, L. M., Diaferia, L., Meregalli, S., & Gatti, A. (2024). Exploring the potential of digital therapeutics: An assessment of progress and promise. Digital health, 10, 20552076241277441.
Ribba, B., Peck, R., Hutchinson, L., Bousnina, I., & Motti, D. (2023). Digital therapeutics as a new therapeutic modality: a review from the clinical pharmacology perspective. Clinical Pharmacology & Therapeutics, 114(3), 578-590.
Denecke, K., May, R., Gabarron, E., & Lopez-Campos, G. H. (2023). Assessing the potential risks of digital therapeutics (DTX): the DTX risk assessment canvas. Journal of Personalized Medicine, 13(10), 1523.
Kim, M., Patrick, K., Nebeker, C., Godino, J., Stein, S., Klasnja, P., ... & Hekler, E. (2024). The digital therapeutics real-world evidence framework: an approach for guiding evidence-based digital therapeutics design, development, testing, and monitoring. Journal of Medical Internet Research, 26, e49208.
Dang, A., Arora, D., & Rane, P. (2020). Role of digital therapeutics and the changing future of healthcare. Journal of Family Medicine and Primary Care, 9(5), 2207-2213.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2025 Vijitha Uppuluri
This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution (CC-BY) 4.0 License that allows others to share the work with an acknowledgment of the work's authorship and initial publication in this journal.
